Intellectual Property

  • July 08, 2026

    Hachette Gets AI Book Cover IP Claims Tossed, For Now

    A New York federal judge on Wednesday tossed a freelance artist's claims that Hachette Book Group used artificial intelligence to create derivative book covers of copyrighted artwork for books authored by romance and thriller novelist Sandra Brown, saying he has not shown substantial similarity between his art and the accused covers.

  • July 08, 2026

    Jazz Patent Suit Over Xyrem Survives Dismissal In NJ

    A New Jersey federal judge has refused to let generic-drug company Tris Pharma Inc. escape a suit claiming its attempt to sell a competing version of Jazz Pharmaceuticals' narcolepsy drug Xyrem infringes a series of patents.

  • July 08, 2026

    Citadel Securities Drops Portofino Suit To Chase UK Judgment

    Citadel Securities has agreed to drop its New York trade secrets lawsuit targeting a Swiss cryptocurrency trading firm launched by two ex-employees in order to focus on enforcing a roughly £6 million ($8 million) judgment it's already won in the dispute, according to documents filed Wednesday.

  • July 08, 2026

    Georgia Healthcare Co. Says Ex-Staff Stole Patient Records

    Two former employees of a Georgia-based healthcare company stole patient and caretaker compensation data days before leaving the company's Pueblo, Colorado, branch for one of its rivals, according to the healthcare company's complaint filed in Colorado federal court Wednesday.

  • July 08, 2026

    Sam Smith Says Song IP Suit Fails Without Proof Of Access

    Pop singers Sam Smith and Normani and their record labels are seeking a favorable ruling in a suit claiming the 2019 song "Dancing With a Stranger" was copied from an older song with a similar name, saying that song's authors were unable to show how the defendants accessed it.

  • July 08, 2026

    Archer Looks To Toss Remainder Of Joby's Trade Secret Suit

    Archer Aviation has asked a California federal judge to throw out what's left of rival electric air taxi-maker Joby Aviation's trade secret suit, saying Joby had ignored the court's instructions to proceed with narrowed claims and instead tried to expand its allegations without adding more substance.

  • July 08, 2026

    Turf Co. Drops Trade Secrets Suit Against Former Exec

    Turf manufacturer FieldTurf USA has agreed to dismiss its lawsuit accusing one of its former executives of taking confidential information when he jumped ship to work for a rival company.

  • July 08, 2026

    Judge Tosses Pearl Drum Carrier Trade Dress Claim, For Now

    A Pennsylvania federal judge has thrown out a trade dress infringement claim in drum-maker Pearl Musical Instrument Co. Ltd.'s intellectual property suit against a Japanese company over marching band drum carriers but gave Pearl another shot at making its case.

  • July 08, 2026

    Bodybuilder Looks To Dodge TM Suit Over 'Mr. America' Title

    A former bodybuilder accused of promoting "Mr. America" competitions without the rights holders' permission has asked a New Jersey federal judge to drop the trademark suit against him or to change the venue to his home state of California.

  • July 08, 2026

    Authors Must Wait To Appeal Meta AI Order In 'Tidy Package'

    Authors suing Meta Platforms Inc. will have to wait to appeal a judge's order that the tech giant's use of their works to train its Llama large language model was fair use, as the judge decided Wednesday to wait until the issue can be presented along with other cases in a "tidy package."

  • July 08, 2026

    Ohio Fuels Litigation Funding Debate As Foreign Ban Is Enacted

    Ohio has enacted a sweeping law that bans all foreign litigation funders from doing business in the Buckeye State, drawing praise from the U.S. Chamber of Commerce and outrage from the litigation finance industry.

  • July 08, 2026

    Handa, Intas Face Patent Suits Over Exelixis Cancer Drug

    Handa Pharmaceuticals and Intas Pharmaceuticals are wrongly trying to bring to market drugs that would compete with Exelixis Inc.'s blockbuster cancer pill Cabometyx before patents on the medication expire, according to a new lawsuit in Delaware federal court.

  • July 08, 2026

    Biggest Rulings For Patent Attys In 2026: A Midyear Report

    The U.S. Supreme Court clarified the pleading standard for induced infringement of skinny labels, and the Federal Circuit opened the door to increased damages for patent owners. Here's what you need to know about these patent cases and other major decisions from the beginning of 2026.

  • July 07, 2026

    6th Circ. Says MillerKnoll Owns Rights To Iconic Lamp Design

    The Sixth Circuit Tuesday refused to disturb a lower court's decision awarding intellectual property rights for late designer George Nelson's iconic bubble lamp to furniture company MillerKnoll, ruling that a 2006 royalty agreement authorized the company to use and own those rights.

  • July 07, 2026

    Mitsubishi Gets Ex-Franchisee Blocked From Using Its Marks

    Mitsubishi Motors North America Inc. on Tuesday secured an order blocking a New Jersey car dealership from continuing to operate as an authorized Mitsubishi dealer after a federal judge determined the automaker likely lawfully terminated the franchise over alleged staffing, training and inventory issues.

  • July 07, 2026

    Regeneron Ducks Amgen's Eylea Antitrust Counterclaims

    A West Virginia federal judge dismissed key counterclaims and defenses Tuesday that Amgen had raised against Regeneron's patent infringement lawsuit targeting bids by multiple would-be rivals to produce biosimilar versions of eye medication Eylea, preserving only arguments that Regeneron waited too long to pursue the patent.

  • July 07, 2026

    8th Circ. Backs Ex-Wilbur-Ellis Workers In Trade Secret Suit

    The Eighth Circuit on Tuesday upheld a lower court's finding that agribusiness Wilbur-Ellis couldn't make its case that several former employees took off with its trade secrets when they went to a competitor.

  • July 07, 2026

    Fed. Circ. Side-Eyes No Sanctions For 'Very Bad' Game Patent

    A Federal Circuit panel seemed ready Tuesday to revive a company's bid for sanctions after it defeated Epic Tech LLC's patent case, with one judge calling the patent "very bad" and saying "if I were the district court judge in this case, I 100% would have granted the attorney's fees."

  • July 07, 2026

    Align's Invisalign Patents Are Infringed But Invalid, Jury Finds

    A Texas federal jury has found that claims in four patents Invisalign maker Align Technology Inc. asserted against orthodontics company ClearCorrect were invalid, but the jurors also rejected ClearCorrect's antitrust claims against Align.

  • July 07, 2026

    Tesla Gets PTAB To Trim Intellectual Ventures Comms Patent

    Elon Musk's Tesla has convinced the Patent Trial and Appeal Board to invalidate a wireless technology patent owned by Intellectual Ventures II, a win for the electric car company in its intellectual property war with the patent holding entity.

  • July 07, 2026

    Auto Accessories Co. Strikes Deal In 'Terrible Towel' Suit

    A Connecticut automotive accessories company has reached a deal with a nonprofit that owns the rights to the "Terrible Towel" trademarks associated with the Pittsburgh Steelers fanbase to resolve a trademark infringement suit.

  • July 07, 2026

    'Terrifier' Filmmaker Can't Slash Actor's Royalties Claims

    The makers of the 2016 independent horror film "Terrifier" were able to shake an actress' claim that nude images of her were illegally circulated but couldn't persuade a judge to throw out her claims for breach of contract and acting in bad faith.

  • July 07, 2026

    Groups Tell 4th Circ. Not To Let Sandoz 'Relitigate' Enbrel

    Pharmaceutical groups and the Washington Legal Foundation backed Amgen in amicus briefs Monday urging the Fourth Circuit not to revive Sandoz's antitrust claims, arguing that if Sandoz wanted to litigate blocked biosimilar competition to Enbrel, it needed to do so when Amgen sued it for patent infringement.

  • July 07, 2026

    AmEx Escapes Rewards Program Patent Suit For Good

    A New York federal judge has permanently dismissed a lawsuit accusing American Express of infringing patents covering loyalty and rewards programs, saying an amended complaint had still not cured the issues the court identified in a previous ruling.

  • July 07, 2026

    USPTO To Set Up Outreach Centers At Ga., Ala. HBCUs

    The U.S. Patent and Trademark Office is planning to launch projects in Georgia and Alabama to connect historically Black colleges and universities in those states with partners to help develop and commercialize inventions.

Expert Analysis

  • The Case For Using Final-Offer Damages Forms In IP Suits

    Author Photo

    Recent Federal Circuit decisions, such as Ollnova v. Ecobee, that scrutinize verdict forms in patent infringement disputes potentially render the final-offer damages selection procedure more attractive, though it should not be seen as a replacement for patent damages doctrine, says Brandon Theiss at Addy Hart.

  • 3 Litigation Strategies To Stay Ahead Of Bad Facts

    Author Photo

    A case with damaging facts can still be won if, instead of avoiding the facts, attorneys proactively address them by carefully selecting a strategy of confronting, containing or reframing, says Allison Rocker at Baker McKenzie.

  • Key Tips For Patenting Antibody-Drug Conjugate Inventions

    Author Photo

    Recent decisions highlight the significant challenges that can arise when patenting antibody-drug conjugates, which require strategic considerations for satisfying heightened written description and enablement requirements, says Xiaoban Xin at FisherBroyles.

  • $885M IBS Drug Verdict Tests Pay-For-Delay Limits

    Author Photo

    The outcome in the Amitiza Antitrust Litigation is significant because it is the first jury trial win for private antitrust plaintiffs in a suit challenging a patent settlement reverse payment since the U.S. Supreme Court adopted the rule-of-reason legal framework in 2013, offering a blueprint for pay-for-delay claims, say attorneys at Katten.

  • Series

    Power To The Paralegals: Burnout As A Structural Problem

    Author Photo

    Law firm leadership can best retain their paralegals not by encouraging self-care, but by seeking top-down structural solutions for the quiet proliferation of responsibilities and the vicarious exposure to client trauma that particularly drive burnout in this vital role, says Erika Sneeringer at Brockstedt Mandalas.

  • Fed. Circ. In May: Being Precise About 'About'

    Author Photo

    The Federal Circuit's decision in Enviro Tech v. Safe Foods last month illustrates the danger in attempting to expand claim scope with words of approximation, potentially causing claims to be invalid for lack of definiteness, say attorneys at Knobbe Martens.

  • Ill. Law Firm MSO Bill Clashes With Court Power, Ethics Rules

    Author Photo

    An Illinois bill prohibiting law firms from certain business arrangements with management service organizations, sent to the governor for signature last week, encroaches upon the courts' constitutional powers and goes beyond the Illinois Rules of Professional Conduct in regulating investment in law-related services, says Matthew O’Hara at Smith Gambrell.

  • The Future Of WDTX Patent Litigation After Judge Albright

    Author Photo

    With U.S. District Judge Christopher Wolfe set to take over much of Judge Alan Albright's patent infringement docket in the Western District of Texas later this year, attorneys should prepare for potential differences in Judge Wolfe's approach to the court's high volume of patent litigation, say attorneys at Sidley Austin.

  • Constructing AI Compliance Plans As State Laws Diverge

    Author Photo

    With Colorado, Connecticut and the federal government recently announcing wildly different approaches to artificial intelligence regulation, creating a workable compliance program means addressing overlapping obligations using shared systems rather than separate silos, say attorneys at Ogletree.

  • As Quantum Computing Evolves, So Do Antitrust Risks

    Author Photo

    Amid quantum computing's increased strategic importance there are five potential antitrust fault lines that may arise not only between quantum developers, but also within and across the layers of the stack as the industry matures, say attorneys at Proskauer.

  • Opinion

    State Courts Must Be Gatekeepers Of Expert Testimony

    Author Photo

    Based on my experience in the state judiciary, emulating federal courts' role as gatekeepers of expert witness testimony would help state court judges maintain the appearance of impartiality and assist juries, thus enhancing the overall confidence people have in their justice system, says Lorie Gildea at Greenberg Traurig.

  • 5 Key Factors Behind USPTO's Inter Partes Review Decisions

    Author Photo

    Though U.S. Patent and Trademark Office Director John Squires has drawn criticism for failing to explain his reasoning in inter partes review decisions, his recent precedential order in Magnolia v. Kurin provides five important insights into his decision-making process, says Christopher Loh at Venable.

  • Series

    Moshing Makes Me A Better Lawyer

    Author Photo

    Entering a mosh pit is much like entering the practice of law — it is difficult, you have to know both the written and unwritten rules, and conduct yourself according to the expectations of each community, says Christopher Deubert at Constangy Brooks.

  • Why Highly Specialized Experts May Risk Exclusion At Trial

    Author Photo

    Expert witnesses with highly specific areas of focus may be vulnerable to exclusion in court, making it important for attorneys to check how potential witnesses' qualifications can be bolstered by their publications and other professional activities, say Evan Weisberg and Christopher Cunio at Hunton, and Kevin Cahill at FTI Consulting.

  • Trump AI Order: Voluntary Framework, Mandatory Implications

    Author Photo

    President Donald Trump's recent executive order promoting the advancement of artificial intelligence innovation and security establishes a new framework for government collaboration with the AI industry, but its classified benchmarking criteria, prerelease framework terms and operational rules will determine whether it establishes de facto compliance expectations, say attorneys at Ropes & Gray.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.